(Q46452782)

22 December 2017

title

Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil (English)

1 reference

22 December 2017

author name string

H Tedesco-Silva

1

1 reference

22 December 2017

M-C Bastien

2

1 reference

22 December 2017

L Choi

3

1 reference

22 December 2017

C Felipe

4

1 reference

22 December 2017

J Campestrini

5

1 reference

22 December 2017

F Picard

6

1 reference

22 December 2017

R Schmouder

7

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

22 December 2017

Transplantation Proceedings

published in

1 reference

22 December 2017

volume

37

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

852-855

1 reference

22 December 2017

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.186

Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.186

Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.186

Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.186

Clinical pharmacokinetics of mycophenolate mofetil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.186

Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.186

Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.186

Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.186

Covalent binding of xenobiotics to specific proteins in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.186

10.1016/J.TRANSPROCEED.2004.12.186

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017